Application open for Grant Opportunity 2025 for Africa Open Lab Initiative by GSK, Africa Open Lab is a GSK initiative focused on advancing scientific research and strengthening research capabilities in sub-Saharan Africa. Our mission is to build research and development (R&D) capacity by funding impactful research projects and supporting early career African scientists and clinicians.
By leveraging GSK’s expertise and fostering catalytic partnerships, Africa Open Lab aims to address Africa’s health challenges while narrowing the research gap between Africa and the rest of the world.
We are committed to supporting the next generation of African scientific leaders. By funding locally responsive and globally relevant research, we aim to contribute to the long-term professional growth of early career scientists. Together, we are driving innovation and building a healthier future for Africa.
Applicants are encouraged to carefully review the full details and submit their applications before the specified deadline to seize this grant opportunity.
Last Date of Submission: 3rd September 2025
Aims (Application open for Grant Opportunity 2025 for Africa Open Lab Initiative by GSK)
By leveraging GSK’s expertise and fostering catalytic partnerships, Africa Open Lab aims to address Africa’s health challenges while narrowing the research gap between Africa and the rest of the world.
Funding Information (Application open for Grant Opportunity 2025 for Africa Open Lab Initiative by GSK)
Up to £100,000 available per award to cover a project for up to 36 months.
The award will offer funding to cover the costs of an appropriate research project including costs for equipment, field work and data collection, consumables, and research assistance.
There will be opportunities to undertake training activities relevant to achieving the aims of the project or research career development, including short courses and training visits to relevant research institutions, to be agreed in consultation with GSK.
In addition to financial support, GSK will provide scientific support throughout the duration of the award term. The level of interaction will be determined through the application process and will be tailored to the individual needs of the project. GSK will explore links with scientists from academic and research groups in Africa and globally to provide mentorship to successful applicants.
Funding is not provided for degree/fellowship tuition fees.
Eligibility Criteria (Application open for Grant Opportunity 2025 for Africa Open Lab Initiative by GSK)
The applicant – you must meet all of the following criteria
- The principal investigator must be an African scientist in the early stages of their research and academic career, defined as: a basic biomedical scientist, clinically qualified investigator, or public health researcher, who has not previously competed successfully as principal investigator for a major research grant (>£100,000); not being more than 5 years past their last postgraduate degree (career breaks, clinical roles and time out of academic research will be taken into consideration).
- The minimum formal qualification required is a graduate degree. Most applicants will be expected to have a MSc, PhD, Pharm D or an MD. Applicants can hold a lecturer appointment, a junior fellowship, or be in another research staff position.
- Must demonstrate that they have a track record and ongoing commitment to health-related research and the skills and experience required to carry out the proposed work. Evidence of research output, including publications in peer reviewed journals (including at least one publication as first or last author), conference publications, presentations at scientific conferences, input into clinical guidelines or policy documents is required.
- Employed by a research or academic institution in SSA which will act as the sponsor to the investigator for the duration of the award. Investigators from all qualifying institutions are welcome to apply. Additionally, applications are strongly encouraged from investigators from historically underrepresented population groups and institution.
- A national of a sub-Saharan African country and based in an institution in SSA.
- Unsuccessful applicants from previous calls who are still eligible to apply may submit a new application.
Clinicians are strongly encouraged to apply
The research project – your project must meet the following criteria
Research proposal of relevance to the understanding of the following disease areas:
Malaria
Tuberculosis and drug-resistant tuberculosis
Drug-resistant bacterial infections
Enteric infections
Research may address one or more of:
Infectious disease epidemiology, pathophysiology, aetiology or prevention and treatment of primary disease
Significant gaps in knowledge about the diversity and causes of disease, their presentation, variations in clinical features and responses to medicines and vaccines
Mechanisms for improving access to and appropriate use of medicines and vaccines.
Research should generate significant data to strengthen further funding proposals that could lead to additional grant funding from other organisations and/or research collaborations in the longer term.
Proposals must demonstrate the specific health needs their research will address and how they will engage with specific stakeholders to bring about change in health policy and practice.
Proposals nested in ongoing trials must include a statement from the PI of the main study confirming the study is complementary and not overlapping with the primary aim of the parent study. The PI should also confirm the availability of samples for their use.
Applicants are strongly advised to ensure that they meet the eligibility criteria before applying
Projects focused on drug or vaccine discovery or those using animal models will not be considered for this round.
How to Apply?
Applications for research grants will be subject to a 2-stage review process. Only those successful at the concept stage will be invited to submit a full application. Recommendations for award funding will be made based on scientific merit.
Follow the steps:
Please go to the GSK Supported Studies website. You will need to register to access the preliminary concept application form.
Complete the preliminary concept application form and submit it along with your CV (Please use the CV Template provided in the application form).
Read the full ‘Conditions for applicants’ before submitting your application.
The selection process:
Completed proposals will be assessed by a scientific panel, including the scientific advisory board of African infectious disease experts and academics from other institutions.
Those assessed as competitive will be invited to submit a full application.
Please note that we will not provide written feedback for unsuccessful applications at the preliminary application stage.
Reviewers will typically assess:
- The eligibility of the applicant
- The scientific merit of the proposed project
- The significance and potential impact of the research
- The potential for scaling up the research
- The potential impact of the project on your career development.
Get full access to the grant information, visit the Official Website Link
No more Google search, join our Whats App Channel and get alerts as soon as we publish a post.
Hey, STEAL our Best Premium Content For Absolutely Free, Check Out the Links below
HOPE these will add value to your existing skills and knowledge
Our information bears no cost (it’s absolutely FREE), don’t let valuable information slip away.
Join our community of avid readers who are always in the know. Subscribe to our website; stay connected and engaged with the latest news, trends, and developments by subscribing today.
(PUSH the bell ICON)
Leverage the power of knowledge to propel your organization to new heights. Don’t miss out to explore our content
- Latest Funds for NGOs,
- NGO Jobs
- Resources (Helpful Guides and Courses)
- Premium Resources
- NGO related articles
Grants for NGOs, NGO Jobs, Resources, Nonprofit Fellowships Programs and Funds for NGOs – Empowering Your Mission
Sharing is Appreciated






